Omda AS (OMDA) Earnings Call Transcript & Summary
May 21, 2026
What were the key takeaways from Omda AS's May 21, 2026 earnings call?
Omda AS reported its Q1 2026 earnings with sales of NOK 119 million, slightly below the same quarter last year. EBITDA was NOK 24 million with a 20% margin, also slightly below the previous year. Despite the soft quarter, management maintained its full-year guidance of NOK 500 million to NOK 525 million in revenue, expecting to exit the year closer to NOK 600 million due to M&A activities. The company emphasized its strategic focus on AI, having established a governance framework to enhance productivity and compliance.
What topics did Omda AS cover?
- Revenue Composition Shift: Recurring revenue increased to 82% of total income in Q1 2026, up from 77% in Q1 2025. Management noted, "recurring revenue is growing normally, which is probably the most important thing when it comes to our top line."
- AI Implementation: Omda established an AI governance framework to support scalable AI adoption across its business units. Management stated, "AI increases our productivity. It doesn't reduce our systems relevance."
- M&A Strategy: The company reiterated its commitment to growth through acquisitions, aiming for 10% to 20% inorganic growth per annum. Management expressed confidence in exiting 2026 with revenue closer to NOK 600 million.
- Currency Impact: Significant currency fluctuations impacted the top line, with only 17% of income in Norwegian kroner. Management noted, "huge movements in currency" affected financial results.
- Professional Services Revenue: Professional Services revenue was lower due to staff focusing on AI projects. Management indicated this was an investment for future efficiency gains.
What were Omda AS's May 21, 2026 results?
- Revenue: NOK 119 million (slightly lower YoY)
- EBITDA: NOK 24 million (20% margin, slightly below last year)
- Recurring Revenue: 82% of total income (vs 77% in Q1 2025)
- Guidance: NOK 500-525 million (maintained for 2026)
- Organic Growth Target: 5% to 10% (maintained long-term target)
- Inorganic Growth Target: 10% to 20% per annum (maintained long-term target)
Omda AS's Q1 2026 results reflect a strategic focus on recurring revenue and AI implementation, despite a slight miss in revenue and EBITDA. The maintained guidance suggests confidence in future M&A-driven growth. Investors should monitor currency impacts and the execution of AI strategies as potential catalysts for future performance.
Earnings Call Speaker Segments
Good morning, everyone, and welcome. We'll walk through the main highlights from the first quarter of 2026, and we'll also cover the guidance. As you can see in the agenda, everything ties together: the Q1 results, the guidance, the AI elements that matter to any business these days, and we completed some deliveries during the first quarter. After that, my colleague Einar will take you through the financials and, naturally, where we stand on M&A, plus the related topics of leverage and financing. Overall, it's an exciting agenda. Let me begin with the key highlights for the first quarter. To start with, sales came in at 119 million NOK, a bit below the first quarter of last year. That said, as always, recurring revenue is growing at its normal pace, which is likely the most important factor for our top line. Next, on our income composition, it's important to grasp the difference when you compare the first quarter of 2025 with the first quarter of 2026 — as you'll see on the first line at the top there, in last year's first quarter, 77% of our income was recurring, whereas in the first quarter, it was 82%.
That tells you something about how the income is composed. The two lines worth examining that account for the gap between the first quarter of '25 and '26 would be professional services and licensing. The licensing portion of our income ties to customer milestones, it's always lumpy, and there are no surprises there. Then, as for professional services, the bulk of it is recurring, with some tied to customer milestones that the customers decide, and we also used a lot of hours in the first quarter to prepare AI, which is a positive, and I'll walk through that in detail. Then you get the top line. On EBITDA, 24 million, a 20% EBITDA margin, also a bit under the same quarter last year. Still, that isn't affecting our plans. This is, of course, the same reason this is somewhat lower as with the income, the top line, and the income composition. That said, let's go through what it means. That's what matters. What do the first quarter highlights mean? Our guidance, we guided last year for this year, and we said 500 to 525 on the top line. At that point in time, the currency was different than today, and of course we cannot control how the currency runs through the year.
But we remain committed to our principles. This slide, I believe, provides an overview of the situation in 2026. To be precise about our existing organic operations: we still anticipate a top line of 500 to 525 for this year. EBITDA, we expect, will remain within the 28% to 32% range. Beyond that, we are a company that acquires. As all of you are aware, that is how Omda has achieved growth over the past 20 years, and we will keep doing so—particularly now in '26 and '27, once profitability is established, we will continue expanding via M&A. The advancement, the mature discussions and projects we are engaged in give us confidence that we can now also confirm we will bring in additional business, allowing us to finish this year closer to 600 rather than 500 in 2026 and on into 2027. In a similar vein, and of even greater significance, we have further dialogues underway that open up possibilities for '27. Many of you have raised with us over recent years that dilution of our EBITDA margin has posed an issue. Two factors differ going forward: the scale of Omda relative to the companies we acquire, and the nature of the acquisition targets we currently have before us.
So that also means we believe that for '27, we'll hold to the position that the existing business, together with what we acquire in '26, will remain within the 28% to 32% range. That's the short-term picture. A bit further out, we have the actuals — you'll recall them from last year — and then we have guidance for this year. Naturally, we'll now get back on track and secure continued growth. Follow our plan. My colleague Einar will walk through some of the status actions on the M&A side and, naturally, the funding side, which forms part of the whole effort to get there. We're quite pleased to be entering the middle of the second quarter now, seeing our guidance in place and having the long-term strategy and actions moving forward. What matters to every company in the world — and each company must do its own unique thing — is handling artificial intelligence. I think in the first quarter we've delivered a lot, which is very, very important, and you can't take it lightly. Particularly for a company like Omda, with a huge responsibility when it comes to life-critical systems, when it comes to regulations, certifications — it's not an easy task.
But that's actually a positive. If it's managed properly, AI is a wonderful thing for Omda and for our customers. That was essentially the focus in the first quarter of 2026. Let me restate my earlier point regarding where we stand on AI as a threat. Naturally, it appears threatening when you consider how code and products might change, and it's reasonable to expect that they will. Code is going to be written. There are millions of distinct codes around the globe, and because of AI they will evolve more and more rapidly each day. Yet in this context, it's hard to believe that code by itself is the thing that counts. The patient and the process surrounding the patient are what count. So AI boosts our productivity. It does not diminish how relevant our systems are. As every software company worldwide is doing nowadays, we are of course taking a totally different approach to development. We must, purely because the available tool sets have shifted even just a few months ago. What we've been doing is, of course, what those two pictures show: the shift from manual work across many of our processes to agent-based AI development.
So what does that actually mean? Does it mean our people don't matter and we just use agents instead? No, that's not what it means at all. In fact, it's the reverse: the heads, the people, the ones who genuinely grasp how complex the processes are within specialized health care and emergency, the people who are prompting in the right way, who are using the agents and designing new agents in the right way — those are the valuable people here. Getting that to happen on its own is not an AI task. Given the criticality, that is not going to happen. What we did in the first quarter matters, and that's why I want to explain it properly. In the first quarter we established an AI governance framework, which is probably among the most important things to do these days, when things are moving so fast. On key achievements, some of them: first of all, we have put this governance framework together and it has been approved. Why does it matter? Because we then support scalable AI adoption, meaning all our 10 business units have tools, they have rules, they have a governance platform, they have everything they can share in order to do things the right way.
That's extremely, extremely important. That's a Q1 delivery. In a similar vein, our quality management system has particular details, and so do our certifications — the governance surrounding these rules, GDPR, MDR, IVDR, EU Act, etc., all of those matter. That carries a lot of weight because it gives us the ability to strengthen where we stand on compliance and our readiness regarding certifications. This matters to our customers. That's the reason we must handle it this way. Internally as well, we've set up formal bodies that handle this across the company-wide situation we're in, and that likewise lowers operational regulatory risk, which is important to the business too. Beyond that, we're a development company, and we have development cycles across 10 different business units. Naturally, managing that in a standardized way is extremely, extremely important. It enables us not only to do it the right way, but also to innovate by having rules for doing it the proper way. That also brings me to innovation — naturally there has to be excitement around AI and all the possibilities on the product side, the efficiency side, and also on the customer side when it comes to developing software.
We've additionally set up an AI Champion Network so that throughout every business unit we can share all the exciting developments taking place. That strengthens Omda's standing when it comes to further developing our mission-critical software as well. I'm very pleased to report that this quarter has been among the most exciting in our history, even though it isn't reflected in the numbers, since a great many of our people at the center, and naturally many people within the business units, have been focused on this instead of, for example, growing professional services — which is part of why professional services came in slightly lower during the first quarter than some of you may have anticipated. I'd say, Einar, when you look at these matters, that my main takeaways here are the numbers, 24 EBITDA, then the guidance, which we are holding to, and then the organic growth, M&A, and of course the fact that we have completed the AI governance framework — do you think that's important as well?
Thank you, Sverre. I have to admit, I don't see AI as the important piece — I still believe human intelligence is what's needed. Perhaps what truly counts is a combination of both. If I've got it right, it's also not a case where you can either take on an AI project or put it off, since it's also part of — you brought up the EU AI Regulation Act — hoo, that's a tongue twister. It takes effect on the 1st of August this year. That's comply or die. It isn't as though being compliant is optional. Given the business we're in, we have to, don't we?
Right. I'd say that's a solid spot for the business to be in. Honestly, it works in our favor. The whole AI frenzy and the danger people associate with AI — the frenzy is genuine, and the danger is genuine too.
This isn't hype or a threat—just possibilities. Let's examine the numbers and walk through the financials. Before I do that, please remember that if any questions come up, you can type them in, and we'll address them following my presentation. Let's look at the financials. As we stated in the report, this quarter was uneventful, and you can see that for yourselves. Income is roughly in line with the same quarter a year ago. What stands out is that recurring revenue continues to grow, while the lumpier portions of the business—license sales—remain lumpy as always. You'll also notice professional services came in lower this quarter versus the same quarter last year. We've noted previously that a substantial share of professional services is recurring or semi-recurring, if you will. The recurring portion remains; the non-recurring portion is absent this quarter. As Sverre mentioned, there are two reasons: first, many of the people who would normally be billing hours have been tied up with AI. We believe that will deliver enormous dividends down the road, because becoming truly skilled at AI—and applying it not merely efficiently but in a secure, safe, and compliant manner—is essential for boosting efficiency and reducing CapEx, getting more from the resources you already have.
This is a future-oriented investment. As for the other side of professional services and seasonality, projects come and go. You'll note we haven't altered our guidance — take that as a signal. Over on the right, there's a new pie chart for your reference. In the report you can see the usual breakdown of where our customers are and where our people are. It also shows which currencies the income arrives in — income comes in various currencies, and that isn't a simple one-to-one match with the countries where customers sit. You might have customers in one country while the income comes in a different currency. What you'll notice is that Swedish krona, euro and pounds — across all those currencies, 80% of the currencies — that's where it sits, while the Norwegian krone has strengthened enormously this year. Currency movements have been massive. In Norwegian krone, a mere 17% of income is actually denominated in Norwegian krone. Just bear in mind that when currency swings are large, it hits the top line. What doesn't get hit — and this is an old favorite of mine — is recurring software revenues.
This chart starts in the first quarter of 2017. That is 9 years, folks. As you can see, they've been rising consistently quarter after quarter, totaling 98 million across the last four quarters — in this quarter — and a 392 million annual run rate. We are nearing 400 million, everyone. Isn't that a beauty? I'd like to — we showed this during the previous presentation, when we presented the fourth quarter results. I'd just like to restate our targets. Guidance is one matter — guidance is what we provide for the current year — but we do have long-term targets. These are our 5-year targets: organic growth of 5% to 10%, and as you can see, it came in lower this quarter. Don't read too much into statistical outliers — that's essentially what I'm saying. We keep that target. We most certainly keep our target of acquired growth of 10% to 20% per annum, and EBITDA above 30% over the long haul. CapEx — bringing CapEx down from 10% to 5%. In recent years, we've been running around 10%. You can see that in the first quarter of this year we're at roughly 9%, and we've stated that we will try to cut CapEx by approximately 1 percentage point each year — we are on track for that.
COGS went from 6% of total revenue down to 5%. You can see that we're having an effect in the first quarter as well — we're heading in the right direction. Salary and personnel expenses, of course, you see they've actually come down from the first quarter last year and from the fourth quarter last year, but they're still higher in percentage points than where we'd like them to be — though there's no drama there. It's more that the income should have been higher than the cost, which is out of control. Other costs, again, are slightly higher — the OpEx, the other costs this quarter — than we'd like them to be; still below the previous target of 15%, but we're not at 10%, slightly above that. Again, there are seasonalities there, but some of it is also linked to certification, MDR, EU Act, ISO 27001, cybersecurity, and the list goes on. There's been a lot of extra costs related to that in this that we've taken this quarter. Last but absolutely not least, we have a bond loan of 500 million NOK. We have said that we think the price on that should be lower.
We believe that over the long term, our interest rate ought to be nearer to 5% rather than 10%. Before I go on, and continuing on that point, let me spend a moment on M&A. As Sverre mentioned, activity in this area remains very high for us. Our database holds over 400 targets. That database is proprietary to us. We handle most of the deal sourcing ourselves — if not all of it. We currently have several dialogues underway. I'm aware that we've repeated this message for a number of quarters. That doesn't make it false. Quite the opposite, I'd say. Things become announceable at the moment they are. Once the babies are born, you'll be invited to take a look. In short, once again, we restate and reiterate our target of 10% to 20% inorganic growth per annum. We'll keep evaluating whether these should be smaller bolt-ons or larger, more transformative deals. We are opportunistic. We can do both. Sometimes you can do the bolt-ons — the three most recent acquisitions were all bolt-on acquisitions — but that doesn't mean we aren't working on, and interested in, the larger, more transformative deals.
The terms must be right, and once they are, we will act. We believe the present market offers opportunities. In our view, all the uncertainty—particularly the uncertainty tied to AI—has generated both uncertainty and opportunity, and more opportunity than challenges when it comes to M&A. To repeat, we are long-term thinkers; we build value over the long term. If we can take advantage of some of the short-term noise to complete deals that build long-term value, we will do so. Again, on the subject of M&A, if I were on the outside looking in, I would be taking a look at Omda, and I would say there is value there in doing the calculation of what the price is versus what the intrinsic value is. We will keep evaluating share buybacks. As you noted at the last AGM, we were granted the proxy to carry out share buybacks. As soon as we can, we will evaluate that. At the end of the day, it is all about capital allocation—where should we put our money. Because we are now moving into territory where we have positive EBITDA, positive cash EBITDA, and perhaps also more attractive funding, we see that we are accumulating cash on the balance sheet, and we can probably make some of the smaller acquisitions using cash from operations or perhaps by drawing on some other kind of facility.
That was the M&A piece. Going back to funding — and this ties into M&A as well, since the two really are connected. Acquisitions are possible, but you have to finance them, particularly the bigger ones. On leverage, we keep deleveraging. As you can see here starting from Q4 '24, we were clearly up in high-yield territory. You can see the three lines on this chart. The top line is roughly where high yield sits on leverage — that's on a scale of 1 to 7 here on this graph. I've placed high yield at around 5 times. Then I've added the BB+ level, which is where you begin to be more bankable. The bottom line, the purple one, sits around 2 times EBITDA on leverage, which is where you move into investment grade. You can see that we're heading toward, kind of, an investment-grade leverage position within a couple of quarters. That's where we stand right now, and we're moving in the right direction. This ought to give us opportunities to evaluate financing alternatives to the current bond loan. Again, lower leverage plus strong performance — continued strong performance — that creates the opportunities. Again, interest rate is the single largest cost, or cash item, in the P&L.
For anyone who hasn't been tracking us, that bond becomes callable in December at 104.3. Up to that point it's a make-whole. Right now it's trading under 200 bips, and to us that's a clear signal that refinancing absolutely belongs on the agenda — and on the agenda it is. Again, I showed you the chart of where the income comes from, what currency our income and revenue arrive in, and we firmly believe the currency of the bond or the financing ought to be tied to where we earn our income. I suppose that's what people call a natural hedge. To sum things up: Q1 was a profitable quarter and an uneventful one — it came and went, but we remain profitable. On 2026, the guidance, we reiterate that guidance, which means — and again, factor in the FX impact and all of that, but still — we reiterate the guidance both organically and inorganically, so that means we have high activity on M&A. Our long-term growth ambitions are maintained and we reiterate those as well. Last but not least, we are actively considering and working on refinancing, so don't be surprised if something happens there.
We're moving into Q&A now, and let me check whether anything has come in. At this moment there aren't any questions, at least none showing on my screen. It doesn't look like we have any questions. Oh, okay — one just appeared right now. Here's one question, and once more, if anything comes to mind, go ahead and type it in and we'll get to it. There's a slight lag between typing your question and it showing up for me — roughly 20 seconds — which is why I'll give it a bit of time. The first question here, and I believe this one is for you, Sverre, concerns the 2026 guidance, and it comes from Sivert, who asks: Could you add some detail on why you're keeping the full-year 2026 guidance? The first quarter came in soft, so why are we holding the guidance?
The key thing is that when you examine order intake at a company such as Omda, it has always consisted of things that could have occurred even years back at the time they were booked. Projects are underway, and one project may show up in a given quarter while others appear in a different quarter. We feel quite confident about what is coming and the timing of it, even if it doesn't arrive in the first quarter, particularly the lumpy portion of licenses. That's one point. Second, the same holds true for milestones, and also for the non-recurring portion of professional services, since those are tied to milestones too. So if we look at the milestones, how do we get back to our guidance when the first quarter comes in soft? The straightforward response is that we gather all of these milestones from 10 separate business units into a single separate latest forecast, and that remains unchanged. That's the genuine answer to how predictability is still intact, even though we have this lumpiness across quarters. Isn't that correct?
That's correct. We have a question from a caller named Jesus, who asks: could you share the constant currency revenue you had in 2026? I'm not exactly certain what you were asking for there, but if the question is about the impact in the first quarter, what we saw is that we entered the end of the year with the euro and the Swedish krona closer to 12 and closer to 1.10, and we finished the quarter substantially lower, and we're now at 10.7 on the euro and 0.98 on the Swedish krona. It wasn't an elevator down, it has been a walk down the stairs. The average across the quarter is that dramatic, but it is heading in that direction. Another one on finance, while I'm at it. We have two questions pending, and this is one of them. It relates to leverage, and I think that's a very interesting question. The question is: what is your thinking around the trade-off between keeping leverage around investment-grade levels with lower cost versus higher leverage and more investment opportunity? That is of course a balance. I guess at the end of the day, it comes down to what kind of leverage is that ideal balance.
What I can tell you is that we don't see ourselves returning to the leverage levels of the past, above 5 times. That would be a stretch. Capital costs are high—probably too high. We reach a point where the cost of capital actually constrains opportunities more than it creates them, since the cost of capital and the discount rate would need to be much higher to take on and complete acquisitions. That's where it stops from a financial standpoint. Conversely, if we stopped acquisitions, we could not only move to investment grade—you'd be closer to investment grade—but be below that, well below it, and have less than 2 times. We would delever very quickly if we halted acquiring and simply focused on optimizing the current business. That would mean we wouldn't be a collector, we wouldn't be an acquirer, we wouldn't be pursuing the strategy we've communicated. That would put an end to it. You have to strike a balance between insanely fast growth with very high leverage and then almost no leverage at all with just organic growth.
So to wrap up, the rationale behind our stated 10% to 20% inorganic growth figure is that we believe that's the point where we can balance sensible leverage against an appealing cost of capital, while also achieving growth that's clearly beyond what organic efforts can deliver. Put another way, if an acquisition sits in that 10% to 20% range, and even when those targets are turnaround or turn-better candidates — which is very often the case — the EBITDA impact won't be substantial. You may hit speed bumps, and perhaps for a quarter or two profitability takes a knock, but the magnitude won't be huge, and it won't push us into very high leverage territory. Smaller speed bumps. That's the other reason we've set this 10% to 20% target. Again, there's no textbook you can simply consult to get the answer to this question. It's also a matter of seeing what opportunities are out there. We believe this is how we've struck a balance. Sverre, here's another question about AI: are the costs tied to AI implementation largely behind us, or do you view them as steady or accelerating?
That is a really good question. When you examine how many of those companies that provide the engine powering this charge for their services, some are costly and some can perhaps be unpredictable in certain ways. What we have done is establish certain rules, which I mentioned in the first quarter, along with a collection of methodologies, components, and solutions that sit under our control. This also means we control the expense involved in paying for these systems. That covers one aspect on the other-cost side and the software side. As for the using hours, I believe we are now entering — in the second quarter and going forward — a totally different kind of daily work, since we now have in place, through the internal approach, the creation of this platform, and we view that as behind us. I would say instead that the opposite will be true going forward: we will see greater efficiency and, as Einar mentioned, it will also assist with CapEx versus sales over time, beginning this year and gradually declining over time thanks to the efficiency these tools deliver. Yes, the bulk of that is behind us.
That's the brief response to a really solid question. I took even less time than you spent on the previous question, since that one was a very lengthy answer.
That answer ran quite long, though the question itself was pretty complex too. Sverre, keep an eye on how much time you devote to the next question.
We’ll see.
Alright.
It really comes down to what’s being asked.
That's really a lengthy question. It breaks down into two sections.
Let's go ahead and take the first question first.
Right, starting with the first one. It has to do with medical imaging — or connected imaging, as we refer to it. Connected imaging accounts for roughly 20% of your revenues, which is accurate. Premium assets in that area, such as Sectra, Pro Medicus, and Intelerad, change hands at very high multiples — around 20 times EBITDA. So the question is: how do your products stack up against those? And what's your view on the strategic value of that division?
One key point matters regarding where we stand relative to larger competitors across various segments. A crucial factor is this: if you look at us broadly against, say, EPR vendors—specifically in terms of delivering the core systems across much of the region, particularly here in the Nordics—those vendors are the ones providing standardized systems in the middle. Then there's also what goes on with commodities, or things like MIRs and MRIs, plus, naturally, all the hardware-related items and the software tied to them. In that respect, none of those are genuine competitors. Certain components may overlap, yet typically we're the specialized party. So for example, in an area such as cardio, we offer mechanisms or functionalities that dig deeply into processes—that's where our focus lies—and instead we integrate and share things with companies such as Sectra, the one just mentioned. Naturally, we have other components in that space, like a stack of XDS, storage and orchestration, and sharing mechanisms for exchanging images, and those could be integrated with any vendor. That's a different category.
Overall, from a strategic standpoint, I believe our emphasis is still going to be on the specialized integratable component as the top priority, while we additionally share integration components and storage components, which partially overlap and partially compete with the big eventers.
Thanks, Sverre. I’ll keep a record of this one. Next, regarding other operating costs: during Q4, you called out certain expenses that weren’t tied to operational activities. Did those stay at roughly the same level in Q1, and should we anticipate any additional non-operational cost over the next few quarters? That’s right, though it is also fairly small. The largest portion of other operational costs consists of software for internal use, office lease, legal assistance, audit, and items of that kind. Then there is the unevenness I mentioned—certification, MDR, and so on—plus possibly some near-term items connected with acquisitions, and so forth, which can be somewhat lumpy. I believe it’s reasonable to say it isn’t a huge amount. Yes, that may fluctuate across quarters. Then there’s a Norwegian item, which appears more like an observation. It states: income measured in constant currency demonstrates that the company achieves revenue growth absent the impact of currency when currency is held constant. I assume this connects to the recommendation: this ought to be calculated and reported. If that isn’t being done today, could it be done going forward? Thank you for raising that. We’ll examine it and see whether we can return to it.
All right, that wraps up the final question—there's one more still waiting. This is the last one. I'll refresh, though keep in mind it takes roughly 20 seconds from the moment you type a question until it shows up here. The question reads: what makes up the other net financial costs—is it mostly FX, or is there something else too? Yes, it's mostly FX. You can spot it in the P&L, and it moves around from quarter to quarter. When FX movements hit hard, you'll typically see a big swing in that line as well. That was the last question. Let me pause for a second or two. Sverre, is there anything else you'd like to add before we close? Anything we've failed to answer from the questions we should have gotten that we haven't?
No, I don’t believe that’s the case. Perhaps if you consider someone who might worry that this is a quiet first quarter, look at ’24, the opening six months of ’24, the opening six months of ’25, and the opening six months of ’26 — you’ll notice that the latter half of the year is consistently the strongest. That’s one point. For those who do the math, you’ll clearly see that profitability in the second quarter will be considerably stronger than in the first quarter, obviously, given what we’ve guided. I think it’s reasonable to say we feel quite comfortable with our guidance. That’s important to state. You probably agree? You’re the numbers guy.
Yeah, that’s tough to argue with. Let me see whether any further questions are in the queue. No — it says here that we’ve hit the end. So it’s time to wrap up. We’ll get back to work. Our Q2 numbers come out on the 27th of August; you can join then and find out whether anything happens before that — we’ll give you a heads-up. Until we speak again, enjoy summer, take care, and stay safe.
Read the full transcript via the API
You're viewing the first half of this call. Get the complete Omda AS transcript - plus 132,000+ transcripts from 7,000+ companies, speaker segments and full-text search - through the EarningsAPI REST API or hosted MCP server.
Get an API key View API docs →For developers and AI pipelines
Programmatic access to Omda AS earnings transcripts and 132,000+ others is available through the
EarningsAPI REST API and the hosted MCP server.
Quarterly plans from $162 - full transcripts, speaker segments, full-text search,
and the /api/v1/transcripts/recent polling endpoint for ETL pipelines.